OCSL
Oaktree Specialty Lending Corporation NASDAQ Listed Jun 12, 2008$12.06
-0.58%
vs $12.13
Mkt Cap $1.0B
52w Low $10.78
37.4% of range
52w High $14.20
50d MA $11.91
200d MA $12.39
P/E (TTM)
21.0x
EV/EBITDA
19.0x
P/B
0.7x
Debt/Equity
1.0x
ROE
2.2%
P/FCF
7.3x
RSI (14)
41.50
ATR (14)
$0.27
Beta
0.56
50d MA
$11.91
200d MA
$12.39
Avg Volume
487.2K
Oaktree Specialty Lending Corporation is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering, and media and advertising sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies with enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.
CIK (SEC)
Phone
213-830-6300
333 South Grand Avenue · Los Angeles, CA 90071 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | BMO | 0.36 | 0.37 | +3.5% | 12.13 | +0.0% | -0.6% | — | — | — | — | — |
| May 5, 2026 | BMO | 0.36 | 0.38 | +5.6% | 12.90 | -4.4% | -5.7% | +2.9% | -2.4% | -0.5% | -0.4% | — |
| Feb 4, 2026 | BMO | 0.38 | 0.41 | +7.9% | 12.54 | -0.6% | -3.3% | +0.0% | +0.1% | +2.0% | -0.5% | — |
| Nov 18, 2025 | BMO | 0.39 | 0.40 | +3.6% | 13.33 | +0.5% | -0.1% | +0.0% | -1.0% | +2.1% | +1.0% | — |
| Aug 5, 2025 | BMO | 0.45 | 0.37 | -17.8% | 13.28 | +0.0% | +0.6% | +0.0% | -0.5% | +0.8% | +0.4% | — |
| May 1, 2025 | BMO | 0.51 | 0.45 | -11.8% | 13.27 | +1.2% | +2.4% | +0.0% | -1.3% | +0.1% | -0.7% | — |
| Feb 4, 2025 | BMO | 0.54 | 0.54 | +0.0% | 15.51 | -0.1% | +1.7% | +0.0% | -1.5% | -0.5% | -0.1% | — |
| Nov 19, 2024 | BMO | 0.56 | 0.55 | -1.8% | 15.61 | -1.0% | +0.4% | +0.0% | -0.8% | +1.9% | +1.1% | — |
| Aug 1, 2024 | BMO | 0.57 | 0.55 | -3.5% | 17.30 | -1.2% | -4.6% | +0.0% | -4.8% | +2.5% | -0.6% | — |
| Apr 30, 2024 | BMO | 0.57 | 0.56 | -1.8% | 19.16 | +0.0% | +1.8% | +0.0% | -1.1% | +0.1% | -0.5% | — |
| Feb 1, 2024 | BMO | 0.61 | 0.57 | -6.6% | 19.52 | -0.6% | +1.0% | +0.0% | -1.0% | +0.7% | -0.3% | — |
| Nov 14, 2023 | BMO | 0.63 | 0.62 | -1.6% | 19.86 | -0.1% | +0.4% | +0.0% | -0.5% | +0.4% | -0.3% | — |
| Aug 3, 2023 | BMO | 0.64 | 0.62 | -3.1% | 20.00 | -0.1% | +0.6% | +0.0% | +0.8% | +0.0% | -1.3% | — |
| May 4, 2023 | BMO | 0.62 | 0.62 | +0.0% | 18.00 | +0.9% | +0.2% | +0.0% | +2.2% | -0.4% | +1.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13 | JP Morgan | Maintains | Neutral → Neutral | — | $11.21 | $11.21 | +0.0% | -1.0% | -2.9% | +3.6% | +0.8% | -0.1% |
| Feb 5 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $12.54 | $12.46 | -0.6% | -3.3% | +0.1% | +2.0% | -0.5% | +0.2% |
| Apr 28 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $14.68 | $14.71 | +0.2% | +1.4% | -1.8% | -1.5% | -7.8% | +2.4% |
| Apr 24 | JP Morgan | Maintains | Neutral → Neutral | — | $14.42 | $14.40 | -0.1% | +1.0% | +0.8% | +1.4% | -1.8% | -1.5% |
| Apr 8 | Keefe, Bruyette & Woods | Maintains | Market Perform → Market Perform | — | $13.25 | $13.61 | +2.7% | -2.3% | +7.4% | -2.5% | +0.1% | +2.1% |
| Nov 22 | Oppenheimer | Maintains | Perform → Perform | — | $15.56 | $15.56 | +0.0% | +1.9% | +1.1% | -0.1% | +1.7% | +0.4% |
| Nov 20 | Keefe, Bruyette & Woods | Maintains | Market Perform → Market Perform | — | $15.61 | $15.45 | -1.0% | +0.4% | -0.8% | +1.9% | +1.1% | -0.1% |
| Nov 20 | B. Riley Securities | Maintains | Neutral → Neutral | — | $15.61 | $15.45 | -1.0% | +0.4% | -0.8% | +1.9% | +1.1% | -0.1% |
| Nov 20 | JP Morgan | Downgrade | Overweight → Neutral | — | $15.61 | $15.45 | -1.0% | +0.4% | -0.8% | +1.9% | +1.1% | -0.1% |
| Nov 19 | JMP Securities | Downgrade | Market Outperform → Market Perform | — | $16.15 | $16.00 | -0.9% | -3.3% | +0.4% | -0.8% | +1.9% | +1.1% |
| Oct 29 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $16.45 | $16.40 | -0.3% | -1.5% | +1.2% | -1.0% | -1.6% | -2.3% |
| Aug 2 | JP Morgan | Maintains | Overweight → Overweight | — | $17.30 | $17.10 | -1.2% | -4.6% | -4.8% | +2.5% | -0.6% | +1.1% |
| Aug 2 | Wells Fargo | Maintains | Overweight → Overweight | — | $17.30 | $17.10 | -1.2% | -4.6% | -4.8% | +2.5% | -0.6% | +1.1% |
| Aug 2 | B. Riley Securities | Maintains | Neutral → Neutral | — | $17.30 | $17.10 | -1.2% | -4.6% | -4.8% | +2.5% | -0.6% | +1.1% |
| Aug 2 | Oppenheimer | Downgrade | Outperform → Perform | — | $17.30 | $17.10 | -1.2% | -4.6% | -4.8% | +2.5% | -0.6% | +1.1% |
| Jul 30 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $18.36 | $18.36 | +0.0% | -1.1% | -0.7% | -4.0% | -4.6% | -4.8% |
| Jul 29 | JP Morgan | Maintains | Overweight → Overweight | — | $18.41 | $18.46 | +0.3% | -0.3% | -1.1% | -0.7% | -4.0% | -4.6% |
| Jul 26 | Wells Fargo | Maintains | Overweight → Overweight | — | $18.11 | $18.15 | +0.2% | +1.7% | -0.3% | -1.1% | -0.7% | -4.0% |
| Apr 12 | JP Morgan | Maintains | Overweight → Overweight | — | $19.48 | $19.47 | -0.1% | -1.1% | -0.2% | +0.3% | +0.7% | +0.3% |
| Mar 26 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $19.37 | $19.37 | +0.0% | +0.2% | +0.5% | +0.8% | -1.7% | +0.9% |
| Feb 2 | Wells Fargo | Maintains | Overweight → Overweight | — | $19.52 | $19.41 | -0.6% | +1.0% | -1.0% | +0.7% | -0.3% | +0.4% |
| Feb 2 | Keefe, Bruyette & Woods | Downgrade | Outperform → Market Perform | — | $19.52 | $19.41 | -0.6% | +1.0% | -1.0% | +0.7% | -0.3% | +0.4% |
| Jan 29 | Wells Fargo | Maintains | Overweight → Overweight | — | $21.54 | $21.54 | +0.0% | -0.7% | +0.4% | -1.4% | -7.8% | +1.0% |
| Jan 8 | B. Riley Securities | Downgrade | Buy → Neutral | — | $20.91 | $20.78 | -0.6% | +0.4% | +0.0% | +1.0% | -0.2% | +0.4% |
| May 5 | Keefe, Bruyette & Woods | Maintains | Outperform → Outperform | — | $18.00 | $18.17 | +0.9% | +0.2% | +2.2% | -0.4% | +1.3% | -1.1% |
| Apr 18 | Wells Fargo | Maintains | Overweight → Overweight | — | $18.96 | $18.87 | -0.5% | -1.6% | +0.9% | -0.7% | +0.4% | +0.4% |
| Mar 13 | JMP Securities | Maintains | Market Outperform → Outperform | — | $18.52 | $18.27 | -1.3% | -0.6% | -0.7% | -0.3% | -0.1% | -2.0% |
| Feb 8 | JP Morgan | Maintains | Overweight → Overweight | — | $20.51 | $20.50 | -0.0% | -2.8% | -1.8% | +1.7% | +1.1% | +0.3% |
| Nov 16 | B. Riley Securities | Maintains | Buy → Buy | — | $20.88 | $21.00 | +0.6% | +2.0% | +0.0% | +0.6% | +0.1% | +0.7% |
| Nov 16 | Wells Fargo | Maintains | Overweight → Overweight | — | $20.88 | $21.00 | +0.6% | +2.0% | +0.0% | +0.6% | +0.1% | +0.7% |
| Oct 24 | Wells Fargo | Maintains | Overweight → Overweight | — | $18.72 | $18.87 | +0.8% | +2.2% | +3.6% | -0.8% | +0.0% | +1.4% |
| Oct 14 | B. Riley Securities | Maintains | Buy → Buy | — | $18.66 | $18.78 | +0.6% | +0.3% | +1.6% | +0.2% | -1.1% | -0.5% |
| Nov 17 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $22.32 | $22.38 | +0.3% | +1.2% | -0.5% | -1.6% | -0.1% | -0.1% |
| Oct 25 | Wells Fargo | Maintains | Overweight → Overweight | — | $22.41 | $22.47 | +0.3% | -0.7% | -0.5% | -0.3% | +0.8% | -0.7% |
| Aug 9 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $21.48 | $21.60 | +0.6% | +1.1% | -0.1% | +0.0% | -0.3% | +0.6% |
| Jun 24 | Oppenheimer | Maintains | Outperform → Outperform | — | $20.19 | $20.40 | +1.0% | +0.9% | -0.6% | +0.0% | -0.9% | +0.0% |
| Aug 17 | Deutsche Bank | Maintains | Buy → Buy | — | $15.09 | $15.12 | +0.2% | -0.2% | -0.4% | -0.6% | +0.2% | +1.0% |
| Jun 19 | Janney Capital | Upgrade | Neutral → Buy | — | $13.26 | $13.86 | +4.5% | +4.1% | -2.0% | +0.0% | -2.3% | +1.4% |
| May 11 | Deutsche Bank | Maintains | Buy → Buy | — | $12.81 | $12.75 | -0.5% | +0.0% | -3.7% | -3.2% | +0.5% | +1.5% |
| May 11 | Wells Fargo | Maintains | Overweight → Overweight | — | $12.81 | $12.75 | -0.5% | +0.0% | -3.7% | -3.2% | +0.5% | +1.5% |
| May 8 | Keefe, Bruyette & Woods | Maintains | Outperform → Outperform | — | $12.12 | $12.27 | +1.2% | +5.7% | +0.0% | -3.7% | -3.2% | +0.5% |
| Apr 27 | Wells Fargo | Maintains | Overweight → Overweight | — | $11.49 | $11.64 | +1.3% | +5.2% | -2.0% | +1.8% | -0.2% | +0.7% |
| Mar 25 | Wells Fargo | Maintains | Overweight → Overweight | — | $7.29 | $7.65 | +4.9% | +21.4% | +19.0% | -1.1% | -4.6% | -2.1% |
| Mar 6 | National Securities | Maintains | Buy → Buy | — | $15.30 | $15.21 | -0.6% | -2.2% | -9.2% | +0.0% | -2.0% | -13.3% |
| Jan 15 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $16.38 | $16.71 | +2.0% | +1.6% | +0.5% | -0.4% | -0.2% | +0.7% |
| Oct 10 | Jefferies | Maintains | Buy → Buy | — | $15.27 | $15.42 | +1.0% | +2.0% | -0.2% | -0.8% | +0.8% | -0.6% |
| Jul 29 | Janney Capital | Maintains | Neutral → Neutral | — | $15.84 | $15.87 | +0.2% | -0.2% | +1.5% | -0.4% | -1.5% | +0.4% |
| Dec 17 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $12.90 | $12.96 | +0.5% | -1.6% | +0.5% | -0.2% | -2.1% | +1.4% |
| Aug 21 | Keefe Bruyette & Woods | Upgrade | Market Perform → Outperform | — | $14.94 | $15.15 | +1.4% | +0.2% | +1.0% | +0.2% | +0.0% | +0.4% |
| Aug 10 | JP Morgan | Maintains | Overweight → Overweight | — | $14.94 | $14.88 | -0.4% | +0.0% | +0.4% | -0.6% | +0.6% | +0.0% |
No insider trades available.
8-K · 2.02
!! High
Oaktree Specialty Lending Corporation -- 8-K 2.02: Earnings Results
Aug 5
8-K · 2.02
!! High
Oaktree Specialty Lending Corporation -- 8-K 2.02: Earnings Results
Oaktree Specialty Lending Corporation reported Q1 2026 earnings results, providing investors with updated financial performance metrics and operational updates for the quarter ending March 31, 2026.
May 5
8-K
BioXcel Therapeutics, Inc. -- 8-K Filing
BioXcel Therapeutics amended its registration rights agreement and warrant terms, updating governance provisions and investor protections in capital structure dealings.
Apr 17
8-K
Oaktree Specialty Lending Corporation -- 8-K Filing
Oaktree Specialty Lending Corporation's March 3, 2026 special meeting was adjourned without voting on a proposal to authorize issuing up to 25% additional shares below net asset value, lacking sufficient stockholder quorum.
Mar 4
8-K
Oaktree Specialty Lending Corporation -- 8-K Filing
Oaktree Specialty Lending Corporation's quarterly investment income declined to $75.1 million ($0.85 per share) in Q1 2026 from $77.3 million ($0.88 per share) in Q4 2025, signaling modest sequential earnings pressure.
Feb 4
Institutional (13F) — Top 0
All ↗
No 13F holders found.
Mutual Funds / ETFs (N-PORT) — Top 6
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Virtus Private Credit Strategy ETF | 65,847 | $811K | Jan 2026 |
| 2 | FT Confluence BDC & Specialty Finance Income ETF | 62,599 | $749K | May 2026 |
| 3 | Novatide Flexible Allocation ETF | 35,793 | $406K | Feb 2026 |
| 4 | RiverNorth Active Income ETF | 29,133 | $329K | Mar 2026 |
| 5 | Bond Index Fund | 100,000 | $97K | Mar 2026 |
| 6 | Small Cap Core Fund | 8,350 | $94K | Mar 2026 |
Valuation
Market Cap
$1.04B
Enterprise Value
$2.45B
P/E (TTM)
21.02x
Forward P/E
7.97x
PEG Ratio
-0.72x
P/B
0.71x
P/S
3.64x
P/FCF
7.29x
EV/EBITDA
18.97x
Shares Out
86.1M
Financials (TTM)
Revenue
$284.9M
Net Income
$49.6M
EBITDA
$128.9M
Free Cash Flow
$142.4M
Op Cash Flow
$142.4M
EPS Basic
$0.39
EPS Diluted
$0.57
EPS Forward
$1.51
Gross Margin
78.5%
Op Margin
45.2%
Net Margin
17.4%
Balance Sheet
Total Assets
$3.00B
Total Liab.
$1.54B
Total Equity
$1.47B
Cash
$79.6M
LT Debt
$1.49B
Book Value/Sh
$17.03
Debt/Equity
1.01x
Current Ratio
11.20
Quick Ratio
11.20
Returns & Growth
ROE
2.2%
ROA
1.0%
ROIC
4.9%
Rev Growth YoY
+60.9%
EPS Growth YoY
-45.8%
Price Returns
2W
+1.3%
1M
+0.8%
3M
-0.2%
6M
+0.0%
12M
-8.7%
Technicals
52W High
$14.20
52W Low
$10.78
50d MA
$11.91
200d MA
$12.39
RSI (14)
41.50
ATR (14)
$0.27
Beta
0.56
Avg Volume
487K
Dividends
Div Rate
$1.72
Div Yield
13.4%
Frequency
4
Ex-Div Date
Mar 16, 2026
Analyst Price Targets
Consensus
$12.00
High
$12.00
Low
$12.00
Median
$12.00
Data updated apr 26, 2026 4:53pm
· Source: financialmodelingprep.com